Edgewell Personal Care (EPC)
(Delayed Data from NYSE)
$39.19 USD
-0.07 (-0.18%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $39.13 -0.06 (-0.15%) 4:40 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Edgewell Personal Care (EPC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$45.50 | $53.00 | $35.00 | 15.89% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for Edgewell Personal Care comes to $45.50. The forecasts range from a low of $35.00 to a high of $53.00. The average price target represents an increase of 15.89% from the last closing price of $39.26.
Analyst Price Targets (8 )
Broker Rating
Edgewell Personal Care currently has an average brokerage recommendation (ABR) of 2.37 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 2.37 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 33.33% and 11.11% of all recommendations. A month ago, Strong Buy made up 33.33%, while Buy represented 11.11%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.37 | 2.37 | 2.37 | 2.37 | 2.37 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/19/2024 | Not Identified | Not Identified | Hold | Hold |
6/12/2024 | Wells Fargo Securities | Christopher Carey | Strong Buy | Strong Buy |
5/9/2024 | Not Identified | Not Identified | Not Available | Moderate Buy |
5/8/2024 | Not Identified | Not Identified | Hold | Hold |
4/8/2024 | Canaccord Genuity | Susan K Anderson | Strong Buy | Strong Buy |
2/8/2024 | UBS | Peter K Grom | Hold | Hold |
10/2/2023 | Goldman Sachs | Jason M English | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.37 |
ABR (Last week) | 2.37 |
# of Recs in ABR | 9 |
Average Target Price | $45.50 |
LT Growth Rate | NA |
Industry | Consumer Products - Staples |
Industry Rank by ABR | 194 of 253 |
Current Quarter EPS Est: | 1.01 |